IP Library Granted Patent US 8,298,835
Granted Patent B2
US 8,298,835 · App. 12/137,156 · Granted Oct 30, 2012

Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining

Assignee: University of Florida Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,298,835
App. No.
12/137,156
Granted
Oct 30, 2012
Kind
B2
Abstract

The present invention identifies biomarkers that are diagnostic of nerve cell injury, organ injury, and/or neuronal disorders. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of nerve injury, the cell(s) involved in the injury, and the subcellular localization of the injury.

Claims (12)

1. A kit for detecting muscle group stress or injury in a subject,

the kit comprising:

(a) a substrate for holding a biological sample isolated from a human subject suspected of having a muscle group injury or stress;

(b) at least one isolated fragment-specific antibody or a plurality thereof that specifically and independently binds to a calpain or caspase-3 induced breakdown product of a troponin protein, wherein the troponin protein breakdown products are breakdown fragments of troponin, troponin C, troponin C-slow skeletal/cardiac (TN-C), skeletal troponin C-fast (STNC), troponin T, troponin T1, T2, T3, troponin t, troponin I1, I2, I3 or mixtures thereof; and

(c) printed instructions for reacting the isolated fragment-specific antibody with the biological sample or a portion of the biological sample to detect the presence or amount of a troponin protein breakdown fragment in the biological sample, wherein said troponin breakdown fragments are detected with said antibodies prepared against the cleavage sites of troponin selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 42, SEQ ID NO: 43, and SEQ ID NO: 44 or mixtures thereof which are present in biological samples of a subject having cardiac muscle injury, and wherein said troponin breakdown fragments are absent in a normal subject not having cardiac muscle injury; or

wherein said troponin breakdown fragments in a normal subject are present in an amount less than 20% of the troponin breakdown fragments found in a subject having smooth or skeletal muscle injury or muscle stress.

2. The kit of claim 1 wherein the biological fluid sample is whole blood, serum, plasma, cerebral spinal fluid (CSF), sweat or saliva.

3. The kit of claim 1 wherein the skeletal or smooth muscle injury or stress is identified with spontaneous or drug induced muscle waste, rhabdomyolysis, muscular dystrophy, cardiac stress, heart failure, cardiac ischemia, myocardial infarction, muscle or exercise overtraining.

4. The kit of claim 1 wherein the kit is used with an immunoassay to react the isolated fragment-specific antibody with the biological sample or a portion of the biological sample to detect the presence or amount of a troponin protein breakdown fragment in the biological sample.

5. The kit of claim 4 wherein the immunoassay is an Enzyme-linked immunosorbent assay (ELISA).

6. The kit of claim 5 wherein the ELISA is a sandwich assay.

7. The kit of claim 1 wherein said specific and independently binding isolated fragment-specific antibodies are prepared against N-terminus or C-terminus epitopes of troponin, troponin C, troponin C-slow TN-C, STNC, troponin T, troponin T1, T2, T3, troponin I, troponin I1, I2, or I3 selected from the group consisting of SEQ ID NO: 51, SEQ ID NO: 52, SEQ ID NO: 53, SEQ ID NO: 54, SEQ ID NO 55, SEQ ID NO: 56, SEQ ID NO 57, SEQ ID NO: 58, SEQ ID NO 59, SEQ ID NO: 60, SEQ ID NO: 61, SEQ ID NO: 62, SEQ ID NO: 63, SEQ ID NO: 64, SEQ ID NO: 65, SEQ ID NO: 66, SEQ ID NO: 81, SEQ ID NO: 82, SEQ ID NO: 83, SEQ ID NO: 84, SEQ ID NO: 131, SEQ ID NO: 132, SEQ ID NO: 133, SEQ ID NO: 134, SEQ ID NO: 135, and SEQ ID NO: 136.

Assignments (2)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jan 12, 2009
From: UNIVERSITY OF FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022090/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2008
From: WANG, KA-WANG KEVIN; LIU, MING CHEN
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 021312/0390 →
Continuity (3)
Division 11106932 · Apr 15, 2005
Provisional Application 60562819 · Apr 15, 2004
Related Publication 20090317805A1 · Dec 24, 2009